Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 16 AL 30

Biological Sex Disparities in Alzheimer's Disease

Almutairi JA, Kidd EJ.

Curr Top Behav Neurosci. 2025;69:79-104. doi: 10.1007/7854_2024_545.

The regulation of miRNAs using curcumin and other polyphenols during the prevention and treatment of Alzheimer's disease

Wang X, Zhang S, Li Y, Zhang Y.

Hum Mol Genet. 2025 Jan 29;34(2):117-127. doi: 10.1093/hmg/ddae154.

Steroidogenic acute regulatory protein mediated variations of gender-specific sex neurosteroids in Alzheimer's disease: Relevance to hormonal and neuronal imbalance

Manna PR, Yang S, Manna C, Waters H, Islam MA, Reddy AP, Rawat P, Reddy PH.

Neurosci Biobehav Rev. 2025 Feb;169:105969. doi: 10.1016/j.neubiorev.2024.105969. Epub 2024 Dec 2.

T-regulatory cells and extracellular vesicles in Alzheimer's disease: New therapeutic concepts and hypotheses

De Sousa RAL, Mendes BF.

Brain Res. 2025 Mar 1;1850:149393. doi: 10.1016/j.brainres.2024.149393. Epub 2024 Dec 11.

Phosphatase activity-based PPM1K: a key player in the regulation of mitochondrial function and its multifaceted impact in diseases

Mao Y, Feng J.

Mol Cell Biochem. 2025 May;480(5):2815-2826. doi: 10.1007/s11010-024-05188-6. Epub 2024 Dec 18.

The AβA2V paradigm: From molecular insights to therapeutic strategies in Alzheimer's disease and primary tauopathies

Diomede L, Conz A, Mosconi M, Stoilova T, Paloni M, Salvalaglio M, Cagnotto A, Colombo L, Catania M, Di Fede G, Tagliavini F, Salmona M.

Pharmacol Res. 2025 Jan;211:107563. doi: 10.1016/j.phrs.2024.107563. Epub 2024 Dec 27.

Drugs repurposing in the experimental models of Alzheimer's disease

Joodi SA, Ibrahim WW, Khattab MM.

Inflammopharmacology. 2025 Jan;33(1):195-214. doi: 10.1007/s10787-024-01608-7. Epub 2025 Jan 3.

Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Dawood RA, Albuhadily AK, Al-Gareeb AI, Abomughaid MM, Klionsky DJ.

Neuropsychopharmacol Rep. 2025 Mar;45(1):e12525. doi: 10.1002/npr2.12525.

Neuroactive Phytoconstituents of Glycyrrhiza glabra for the Treatment of Alzheimer's Disease

Verma M, Mohd Siddique MU, Singh NK.

Curr Top Med Chem. 2025;25(10):1251-1265. doi: 10.2174/0115680266357793241223100307.

C/EBPβ in Alzheimer's disease: An integrative regulator of pathological mechanisms

Luo X, Liang J, Lei X, Sun F, Gong M, Liu B, Zhou Z.

Brain Res Bull. 2025 Feb;221:111198. doi: 10.1016/j.brainresbull.2025.111198. Epub 2025 Jan 7.

Gut microbiota in Alzheimer's disease: Understanding molecular pathways and potential therapeutic perspectives

Lista S, Munafò A, Caraci F, Imbimbo C, Emanuele E, Minoretti P, Pinto-Fraga J, Merino-País M, Crespo-Escobar P, López-Ortiz S, Monteleone G, Imbimbo BP, Santos-Lozano A.

Ageing Res Rev. 2025 Feb;104:102659. doi: 10.1016/j.arr.2025.102659. Epub 2025 Jan 10.

Evolution of Human Susceptibility to Alzheimer's Disease: A Review of Hypotheses and Comparative Evidence

August I, Gagneux P, Semendeferi K, Marchetto MC.

Evol Anthropol. 2025 Mar;34(1):e22054. doi: 10.1002/evan.22054.

Cuproptosis and copper as potential mechanisms and intervention targets in Alzheimer's disease

Li Y, Han Y, Shu Q, Kan YK, Wang Z.

Biomed Pharmacother. 2025 Feb;183:117814. doi: 10.1016/j.biopha.2025.117814. Epub 2025 Jan 13.

Senescence accelerated mouse-prone 8: a model of neuroinflammation and aging with features of sporadic Alzheimer's disease

Ong J, Sasaki K, Ferdousi F, Suresh M, Isoda H, Szele FG.

Stem Cells. 2025 Feb 12;43(2):sxae091. doi: 10.1093/stmcls/sxae091.

Mathematical models on Alzheimer's disease and its treatment: A review

Maji M, Khajanchi S.

Phys Life Rev. 2025 Mar;52:207-244. doi: 10.1016/j.plrev.2025.01.004. Epub 2025 Jan 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias